Fuan Pharmaceutical (Group) Co., Ltd.

Shenzhen Stock Exchange 300194.SZ

Fuan Pharmaceutical (Group) Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.20

Fuan Pharmaceutical (Group) Co., Ltd. Debt to Equity Ratio is 0.20 for the year ending December 31, 2023, a 11.66% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Fuan Pharmaceutical (Group) Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.18, a -25.39% change year over year.
  • Fuan Pharmaceutical (Group) Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.24, a 65.34% change year over year.
  • Fuan Pharmaceutical (Group) Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.15, a 405.98% change year over year.
  • Fuan Pharmaceutical (Group) Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.03, a 23.14% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300194.SZ

Fuan Pharmaceutical (Group) Co., Ltd.

Description

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells pharmaceutical intermediates, bulk drugs, and formulations in the People's Republic of China. It offers APIs and intermediates, as well as formulations, such as anti-infective, cardiovascular, digestive, leaflet, and other products. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. Fuan Pharmaceutical (Group) Co., Ltd. was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.

StockViz Staff

February 2, 2025

Any question? Send us an email